Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LeMaitre VascularLMAT +0.78%100 OCF Yield % is 4.45 as of Aug. 07, 2026, which is 45% above its 10-year median of 3.07. GuruFocus rates LMAT with a GF Score™ of 100/100 and a GF Value™ of $95.26 (Modestly Undervalued). Among 848 Medical Devices & Instruments companies, LeMaitre Vascular ranks better than 63.33% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
LeMaitre Vascular OCF Yield % Related Terms
LeMaitre Vascular OCF Yield % Historical Data
* Premium members only.
The historical data trend for LeMaitre Vascular's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, LeMaitre Vascular's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LeMaitre Vascular OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LeMaitre Vascular's OCF Yield % distribution charts can be found below:
* The bar in red indicates where LeMaitre Vascular's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LeMaitre Vascular (LMAT) has a OCF Yield % of 4.45 as of Aug. 07, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on LeMaitre Vascular and its competitors. This is 45% above median its historical median of 3.07. Over the past decade, LeMaitre Vascular's OCF Yield % has ranged from 1.51 to 4.57. According to the industry distribution chart, LeMaitre Vascular ranks #311 out of 848 companies in the Medical Devices & Instruments industry, placing it in the top 36.7%.
Is LeMaitre Vascular's OCF Yield % too high?
LeMaitre Vascular's current OCF Yield % of 4.45 is 45% above median its 10-year median of 3.07. Over the past 10 years, this metric has ranged from a low of 1.51 to a high of 4.57. The Medical Devices & Instruments industry median OCF Yield % is 1.57. LeMaitre Vascular's value of 4.45 is 183.4% above this industry median. Based on the distribution chart, LeMaitre Vascular ranks #311 out of 848 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, LeMaitre Vascular has a GF Score™ of 100/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does LeMaitre Vascular's OCF Yield % compare to PLSE and XRAY?
According to the Medical Devices & Instruments industry distribution chart, LeMaitre Vascular ranks #311 out of 848 companies for OCF Yield %. This puts LeMaitre Vascular in the upper half of its industry. The industry median OCF Yield % is 1.57. LeMaitre Vascular's value of 4.45 is 183.4% above this benchmark. Historically, LeMaitre Vascular's own OCF Yield % has ranged from 1.51 to 4.57 over the past decade. While the company's 10-year median is 3.07 vs. the industry median of 1.57, LeMaitre Vascular has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.57, based on 848 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LeMaitre Vascular's current OCF Yield % of 4.45 is 183.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on LeMaitre Vascular and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LeMaitre Vascular's current OCF Yield % is 4.45, which is 45% above median its own 10-year median of 3.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LeMaitre Vascular stock overvalued right now?
Based on GuruFocus' analysis, LeMaitre Vascular (LMAT) is currently considered Modestly Undervalued. The stock's GF Value™ is $95.26, compared to a current price of $81.45 — trading 14.5% below its estimated fair value. The current OCF Yield % is 4.45, which is 45% above median its 10-year median of 3.07 and 183.4% above the Medical Devices & Instruments industry median of 1.57. LeMaitre Vascular's overall GF Score™ is 100/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For LeMaitre Vascular (LMAT), the current OCF Yield % is 4.45 as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LeMaitre Vascular (LMAT) Overvalued in 2026?
Based on GuruFocus' analysis, LeMaitre Vascular stock appears to be undervalued.
The current stock price of $81.45 is trading 14.5% below its estimated GF Value™ of $95.26.
GuruFocus considers LeMaitre Vascular to be Modestly Undervalued.
Key valuation signals for LMAT:
OCF Yield %: 4.45 (45% above median its 10-year median of 3.07)
GF Value™: $95.26 vs. price of $81.45 (14.5% below fair value)
Industry Position: 183.4% above the Medical Devices & Instruments median (#311 of 848)
No single metric tells the full story. See the LMAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
100GF Score
Get the complete analysis for LMAT
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LMAT has been successfully added to your 
